BI-RADS 3 breast lesions may not require 6-month check

08/20/2013 | (free registration)

Most ultrasound-detected BI-RADS 3 lesions were found to be not malignant at six- and 12-month follow-ups, according to a study published in Radiology that analyzed data from the American College of Radiology Imaging Network 6666 trial. Of 745 BI-RADS 3 lesions found with ultrasound, 124 were biopsied and only six were malignant. "Breast density notification legislation is driving increased use of screening ultrasound," said researcher Dr. Richard Barr. "And since we're conducting more ultrasound screening, we're finding more BI-RADS 3 lesions."

View Full Article in: (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC